Compound atlas
Cognitive

Cerebrolysin

PeptidePrescription drug
Half-life
24h
approx. mean t½
Dose range
5–10 ml
typical, not prescriptive
Category
Cognitive
primary use-case
Single-dose decay
t½ = 24h · first-order model
~4d
to clear
1× t½
50%
remaining
2× t½
25%
remaining
~4× t½
6%
remaining
0%25%50%75%100%0m24h2d3d4d5d

How a single dose clears, assuming first-order elimination. The half-life is the biggest driver of how often you dose — start a cycle to see your own cumulative concentration curve.

Overview

A porcine-brain-derived peptide preparation used clinically in some countries for stroke, dementia, and traumatic brain injury.

Mechanism of action

Supplies low-molecular-weight neuropeptides with neurotrophic, neuroprotective effects resembling endogenous growth factors.

Typical protocol

5–10 ml IM/IV daily in supervised courses of several weeks.

Storage

Store per label; protect from light.

Disclaimer

This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.